Longevity Drug Breakthrough Follows Launch of Oral Weight-Loss Pill

Kristen Fortney anticipates breakthroughs in longevity drugs after Novo Nordisk launched a 299 dollar oral weight-loss pill in the USA.BioAge Labs is collaborating with Eli Lilly and Novartis to target aging biology and muscle retention through human protein analysis.Analysts at Goldman Sachs expect oral medications to capture a quarter of the 95 billion dollar global market by 2030 as accessibility grows.